BioNxt Solutions expands drug delivery tech for autoimmune diseases, targeting growth markets.

BioNxt Solutions Inc. is expanding its drug delivery technologies, focusing on autoimmune diseases like MS, MG, LN, and RA, using sublingual, transdermal, and oral systems. The company is also developing products for the longevity market, aiming to improve patient compliance and address unmet medical needs. The global markets for these conditions are projected to grow significantly by 2033.

November 25, 2024
5 Articles